With ACMG well-underway over in Charlotte, North Carolina we have put together our very own round-up of those who received awards yesterday. Check back tomorrow for round two.
Studies using CRISPR on monkeys look encouraging, but more needs to be done before the gene-editing technology can be used on humans.
A new cancer cell-based assay could help doctors diagnose cancer, better monitor the disease, and take a step closer to customised treatment for individual patients.
Critically ill infants in the Australian state of Victoria are now to be given access to rapid genomic sequencing under a new government-funded programme.
Scientist Andrew Feinberg calls for more integration between two fields of DNA-based research: genetics and epigenetics.
Experts in medicine and law are urging the US to allow for the replacement of mutation-bearing mitochondria to prevent fatal illnesses in children.
Combining a cancer therapy with a second drug therapy that helps suppress tumour blood vessels found in cancer cells can help to significantly reduce the spread of breast cancer tumours while also causing cancer cell death.
With the demand for direct-to-consumer genetic tests on the rise, a new analysis has questioned how reliable the results really are.
Researchers have taken a step closer to the goal of precision medicine for treating glaucoma and other neurodegenerative vision diseases.
Head of the FDA, Scott Gottlieb has suggested some ways in which pharma giants could rethink their business models, to help unproductive drugmakers.